AzTrials
AzTrials

MortalityNCT04740619

Natural Orifice Specimen Extraction in Sigmoid Volvulus

An observational study of Mortality and Morbidity, run by Dr. Ersin Arslan Education and Training Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sigmoid resection can be performed using conventional and laparoscopic methods. There are few publications in the literature reporting specimen removal from the natural hole in patients with a diagnosis of sigmoid volvulus. Read more about this study

Who is it for?
Any age
Conditions the study is for
Mortality, Morbidity
What is being tested?
Natural Orifice Specimen Extraction
Type of treatment
Surgery or procedure
How many people
8 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2018to 20 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: sigmoid volvulus patients

Who may be able to join

  • transanal for specimen extraction by elective laparoscopic sigmoid colon resection

Who cannot join

  • emergency surgery
  • conventional open sigmoid resection
  • conventional laparoscopic sigmoid resection

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Dr. Ersin Arslan Training and Resource Hospital

    Gaziantep

Other trials in Turkey (Türkiye)

About this study

Official title: Natural Orifice Specimen Extraction in Sigmoid Volvulus Patients

Sigmoid resection can be performed using conventional and laparoscopic methods. There are few publications in the literature reporting specimen removal from the natural hole in patients with a diagnosis of sigmoid volvulus. Here, the investigators aimed to present the literature that transanal specimen removal is a technically feasible method after laparoscopic surgery in patients with sigmoid volvulus.

Read the detailed description

Sigmoid resection can be performed using conventional and laparoscopic methods. There are few publications in the literature reporting specimen removal from the natural hole in patients with a diagnosis of sigmoid volvulus. Here, the investigators aimed to present the literature that transanal specimen removal is a technically feasible method after laparoscopic surgery in patients with sigmoid volvulus. The documents of patients who were operated on for sigmoid volvulus between 2018 and 2019 were retrospectively reviewed. Patients who had been used transanal for specimen extraction by elective laparoscopic sigmoid colon resection were included in the study. Patients' gender, age, comorbidity, operation time, operative difficulties, complications, length of stay, and mortality findings were analyzed. Laparoscopic sigmoid resection and transanal specimen removal were performed in eight patients. Specimen extraction surgery from the natural hole is increasingly preferred. the investigators think that natural hole surgery can be performed more easily and reliably in sigmoid volvulus due to the large diameter of the colon.

Conditions
Mortality, Morbidity
Being tested
Natural Orifice Specimen Extraction
Keywords
colon, volvulus, natural orifice, laparoscopy, sigmoid
Medical subject headings
Intestinal Volvulus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Natural Orifice Specimen ExtractionProcedure or surgery

    Natural Orifice Specimen Extraction via transanal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mortality

    mortality after this procedure

    Measured: 1 year

  2. morbidity

    morbidity after this procedure

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2021
  2. Study start1 Jan 2018
  3. Primary completion15 Jan 2020
  4. Study completion20 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04740619
Sponsor's protocol ID
2020/178
Status last verified
Feb 2021
First submitted
1 Feb 2021
Last updated
5 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mortality and Morbidity, run by Dr. Ersin Arslan Education and Training Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mortality (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in